About Microplate Dx
Microplate Dx is a company based in Glasgow (United Kingdom) founded in 2017 by Paul Hoskisson, Damion Corrigan, and Stuart Hannah.. Microplate Dx has raised $4.37 million across 4 funding rounds from investors including University of Strathclyde, Scottish Enterprise and Centre for Process Innovation. Microplate Dx offers products and services including Microplate Dx Technology and RapidPlate Technology. Microplate Dx operates in a competitive market with competitors including Diagnochip, ODx Innovations, UTI-lizer, PhenUtest and ARDIS, among others.
- Headquarter Glasgow, United Kingdom
- Founders Paul Hoskisson, Damion Corrigan, Stuart Hannah
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Microplate Dx Limited
- Date of Incorporation 10 Aug, 2021
- Jurisdiction GLASGOW, SCOTLAND
-
Annual Revenue
$47.57 K (USD)0as on Apr 30, 2022
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.37 M (USD)
in 4 rounds
-
Latest Funding Round
$644.57 K (USD), Seed
Sep 04, 2025
-
Investors
University of Strathclyde
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Microplate Dx
Microplate Dx offers a comprehensive portfolio of products and services, including Microplate Dx Technology and RapidPlate Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides rapid antibiotic susceptibility testing for infections with high accuracy.
Offers quick diagnostics for urinary tract infections using advanced algorithms.
Unlock access to complete
Funding Insights of Microplate Dx
Microplate Dx has successfully raised a total of $4.37M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $644.57 thousand completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Seed — $644,569
-
First Round
First Round
(09 Dec 2022)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2025 | Amount | Debt – Conventional - Microplate Dx | Valuation |
investors |
|
| Sep, 2025 | Amount | Seed - Microplate Dx | Valuation |
investors |
|
| Sep, 2023 | Amount | Seed - Microplate Dx | Valuation | SIS Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Microplate Dx
Microplate Dx has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Strathclyde, Scottish Enterprise and Centre for Process Innovation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deepbridge Capital is focused on tax-efficient investment opportunities.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on social impact companies
|
Founded Year | Domain | Location | |
|
Public university offering multiple degrees and courses across diversified streams
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Microplate Dx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Microplate Dx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Microplate Dx Comparisons
Competitors of Microplate Dx
Microplate Dx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Diagnochip, ODx Innovations, UTI-lizer, PhenUtest and ARDIS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Designs and develops diagnostic devices for detecting urinary infections.
|
|
| domain | founded_year | HQ Location |
Provides rapid testing for antibiotic susceptibility in urinary tract infections and healthcare support.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic tests for urinary tract infections are provided.
|
|
| domain | founded_year | HQ Location |
Develops innovative diagnostic kits for urinary tract infections.
|
|
| domain | founded_year | HQ Location |
Develops innovative diagnostic technologies for pelvic floor disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Microplate Dx
Frequently Asked Questions about Microplate Dx
When was Microplate Dx founded?
Microplate Dx was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Where is Microplate Dx located?
Microplate Dx is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.
Who is the current CEO of Microplate Dx?
Stuart Hannah is the current CEO of Microplate Dx. They have also founded this company.
Is Microplate Dx a funded company?
Microplate Dx is a funded company, having raised a total of $4.37M across 4 funding rounds to date. The company's 1st funding round was a Seed of $3.12M, raised on Dec 09, 2022.
What is the annual revenue of Microplate Dx?
Annual revenue of Microplate Dx is $47.57K as on Apr 30, 2022.
What does Microplate Dx do?
Microplate Dx was founded in 2017 in Glasgow, United Kingdom, within the diagnostics sector. The Rplate platform is utilized to integrate hardware and data processing algorithms for conducting swift antibiotic susceptibility tests targeting urinary tract infections. Focus is placed on identifying drug-resistant infections through these operations, supporting clinical decision-making in healthcare settings.
Who are the top competitors of Microplate Dx?
Microplate Dx's top competitors include UTI-lizer, ARDIS and Diagnochip.
What products or services does Microplate Dx offer?
Microplate Dx offers Microplate Dx Technology and RapidPlate Technology.
Who are Microplate Dx's investors?
Microplate Dx has 7 investors. Key investors include University of Strathclyde, Scottish Enterprise, Centre for Process Innovation, Deepbridge Capital, and SIS Ventures.